HLB PANAGENE Co., Ltd.

PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics.

We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. 

PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories.
(EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) 

Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. 
(HPV, STD, CRE, TB/NTM)

Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user.  The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings.
(Viral, FFPE, cfDNA extraction kits)

PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products.

We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.